Noile-Immune Biotech Inc.
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
4893 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区芝大門二丁目１２番１０号
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Noile-Immune Biotech Inc. is a clinical-stage biotechnology company focused on the development and commercialization of novel cancer immunotherapies. The company specializes in CAR-T cell therapy aimed at treating solid tumors, a significant challenge in oncology. Its core is the proprietary PRIME (Proliferation-Inducing and Migration-Enhancing) technology, a next-generation platform designed to augment the efficacy of CAR-T cells. Noile-Immune advances its therapeutic pipeline through in-house research and strategic partnerships with academic and corporate entities, with the mission to create transformative treatments for cancer patients.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Noile-Immune Biotech Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-08 09:15 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-08-08 09:14 |
Interim Report
半期報告書－第11期(2025/01/01－2025/12/31)
|
Japanese | 143.9 KB | |
| 2025-04-01 09:11 |
Regulatory News Service
臨時報告書
|
Japanese | 23.5 KB | |
| 2025-03-28 05:44 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2025-03-28 05:43 |
Regulatory News Service
内部統制報告書－第10期(2024/01/01－2024/12/31)
|
Japanese | 21.2 KB | |
| 2025-03-28 05:42 |
Annual Report
有価証券報告書－第10期(2024/01/01－2024/12/31)
|
Japanese | 4.1 MB | |
| 2024-10-15 05:07 |
Regulatory News Service
訂正確認書
|
Japanese | 8.2 KB | |
| 2024-10-15 05:06 |
Regulatory News Service
訂正半期報告書－第10期(2024/01/01－2024/12/31)
|
Japanese | 124.4 KB | |
| 2024-08-13 05:02 |
Interim Report
半期報告書－第10期(2024/01/01－2024/12/31)
|
Japanese | 150.3 KB | |
| 2024-08-13 05:00 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-05-14 10:07 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-05-14 10:05 |
Quarterly Report
四半期報告書－第10期第1四半期(2024/01/01－2024/03/31)
|
Japanese | 117.7 KB | |
| 2024-04-02 06:49 |
Regulatory News Service
臨時報告書
|
Japanese | 22.2 KB | |
| 2024-03-29 06:19 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-03-29 06:18 |
Regulatory News Service
内部統制報告書－第9期(2023/01/01－2023/12/31)
|
Japanese | 21.2 KB |
Automate Your Workflow. Get a real-time feed of all Noile-Immune Biotech Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Noile-Immune Biotech Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
